V. Jiménez

发表

Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens.

M. Esteban, C. E. Gómez, J. L. Nájera, 2009, Vaccine.

Differential CD4 (cid:1) versus CD8 (cid:1) T-Cell Responses Elicited by Different Poxvirus-Based Human Immunodeﬁciency Virus Type 1 Vaccine Candidates Provide Comparable Efﬁcacies in Primates (cid:1) †

J. Heeney, R. Wagner, M. Esteban, 2008 .

Improved NYVAC-Based Vaccine Vectors

G. Pantaleo, R. Sékaly, J. Tartaglia, 2011, PloS one.

Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L

Susana Guerra, M. Esteban, J. Gil, 2002, Oncogene.

Deletion of the Viral Anti-Apoptotic Gene F1L in the HIV/AIDS Vaccine Candidate MVA-C Enhances Immune Responses against HIV-1 Antigens

G. Pantaleo, C. Sorzano, T. Calandra, 2012, PloS one.

Multiepitope polypeptide of the HIV-1 envelope induces neutralizing monoclonal antibodies against V3 loop.

M. Montero, J. Madrazo, C. Duarte, 1994, AIDS research and human retroviruses.

Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.

G. Pantaleo, R. Wagner, P. Liljeström, 2007, Vaccine.

Genetic characterization of the V3 loop sequences of 21 HIV type 1 Spanish isolates from hemophilia patients.

M. Ortíz, M. Magallón, A. García-Sáiz, 1998, AIDS research and human retroviruses.

Differential CD4 (cid:1) versus CD8 (cid:1) T-Cell Responses Elicited by Different Poxvirus-Based Human Immunodeﬁciency Virus Type 1 Vaccine Candidates Provide Comparable Efﬁcacies in Primates (cid:1) †

J. Heeney, R. Wagner, M. Esteban, 2022 .

Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02).

Felipe García, M. Plana, G. Pantaleo, 2011, Vaccine.

The HIV/AIDS Vaccine Candidate MVA-B Administered as a Single Immunogen in Humans Triggers Robust, Polyfunctional, and Selective Effector Memory T Cell Responses to HIV-1 Antigens

Felipe García, M. Plana, J. Gatell, 2011, Journal of Virology.

Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C

C. Melief, G. Pantaleo, F. Sallusto, 2012, Retrovirology.

Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C

C. Melief, G. Pantaleo, F. Sallusto, 2012, Retrovirology.

Removal of Vaccinia Virus Genes That Block Interferon Type I and II Pathways Improves Adaptive and Memory Responses of the HIV/AIDS Vaccine Candidate NYVAC-C in Mice

C. Sorzano, M. Esteban, B. Perdiguero, 2012, Journal of Virology.

NYVAC-C in Mice of the HIV/AIDS Vaccine Candidate Improves Adaptive and Memory Responses Block Interferon Type I and II Pathways Removal of Vaccinia Virus Genes That

M. Esteban, B. Perdiguero, S. Sorzano, 2012 .

Virological and Immunological Characterization of Novel Nyvac- Based Hiv/aids Vaccine Candidates Expressing Clade C Trimeric Soluble Gp140(zm96) and Gag(zm96)-pol-nef(cn54) as Virus-like Particles the Generation of Vaccines against Hiv/aids Able to Induce Long-lasting Protective Immunity Remains a M

G. Pantaleo, C. Sorzano, T. Calandra, 2022 .

Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.

G. Pantaleo, M. Graf, R. Wagner, 2007, Vaccine.

Broadly reactive antibodies against a gp120 V3 loop multi-epitope polypeptide neutralize different isolates of human immunodeficiency virus type 1 (HIV-1).

M. Montero, O. Reyes, A. Menendez, 1997, Vaccine.

Regulated expression of nuclear genes by T3 RNA polymerase and lac repressor, using recombinant vaccinia virus vectors

W. Mcallister, M. Esteban, D. Rodríguez, 1990, Journal of virology.

Use of persistent infections with vaccinia virus recombinants to introduce alterations in foreign proteins: an application to HIV-1 env protein.

M. Esteban, D. Rodríguez, V. Jiménez, 1996, Virus research.

Virological and Immunological Characterization of Novel NYVAC-Based HIV/AIDS Vaccine Candidates Expressing Clade C Trimeric Soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as Virus-Like Particles

G. Pantaleo, C. Sorzano, T. Calandra, 2014, Journal of Virology.